Automatic and Conventional Methods of Hypertensive Patients Monitoring
ConditionPrimary Hypertension
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-70
SponsorAssiut University
About this trial
comparing automatic blood pressure measurments methods with conventional office methods in follow up and monitoring of hypertensive patients and predicting hypertension mediated organ damage .
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Patients who were screening for suspected hypertention or white coat hypertention .
medically underserved population .
primary arterial hypertention .
high risk hypertensive patients [resistant hypertension ,patients with poor medication adherance ]
Disqualifiers
patients with secondary causes of hypertention
patients with other cardiac diseases [heart faliure ,valvular heart diseases ]
chronic illness affect blood pressure as chronic kideny disease .
Trial population
A calculated minimum sample of 620 male and female hypertensive patients aged more than 18 years old recruited from outpatient clinic of assiut cardiology departement will be randomly assigned 1:1 design.
Trial design
Design model
Other
Time perspective
Prospective
Treatments tested in this trial
blood pressure measurments devices
Devicemeasure arterial blood pressure by arm cuff devises
Treatment groups
620 Participants
are divided into 2 treatment groupsGroup A: Group 11 intervention
Group B: group 21 intervention
Trial outcomes
Primary outcomes
1
predictive accuracy of automatic blood pressure measurments versus conventional office based measurments in identifying patient at risk of hypertension mediated organ damage [HMOD] .
this outcomes will be assessed by measuring systolic and diastolic blood pressure using both automated devices \[eg omron HEM -907\] and conventional manual sphygmomanometers in a seated postion ,after 5 minutes of rest .measurments will be taken in duplicate on two separate visits ,one week apart and the average readings will be used for analysis .the presence of HMOD will be evaluated through echocardiographic assessment of left ventricular hypertrophy \[LVH \] and microalbuminuria .correlation and predictive value \[ sensitivity , specificity\] will be calculated to compare both methods
Time frame
over 6 months follow up periodLocations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov
This trial is not recruiting at the moment. You can still explore other options: